|
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 17935/22952 (78%)
Visitors : 7414579
Online Users : 278
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
https://ir.csmu.edu.tw:8080/ir/handle/310902500/23426
|
Title: | Efficacy of Probiotic Milk Formula on Blood Lipid and Intestinal Function in Mild Hypercholesterolemic Volunteers: A Placebo-control, Randomized Clinical Trial |
Authors: | Chiu, HF;Fang, CY;Shen, YC;Venkatakrishnan, K;Wang, CK |
Keywords: | Probiotics;Cholesterol;Microbiota;Hypercholesterolemic;Fecal movement |
Date: | 2021 |
Issue Date: | 2022-08-05T09:37:05Z (UTC)
|
Publisher: | SPRINGER |
ISSN: | 1867-1306 |
Abstract: | Several studies have reported that probiotics could modulate host lipid metabolism via altering the intestinal microbiota. Hence, the current study was aimed to assess the efficacy of a mixture of probiotic-contained milk formula (PMF) with three different bacterial strains [Lactobacillus acidophilus (La5), Lactobacillus casei (TMC), Bifidobacterium lactis (Bb12)] on lipid profile and intestinal function in healthy mild hypercholesterolemic volunteers. Totally, 40 healthy mild hypercholesterolemic subjects (180-220 mg/dL) were randomly assigned into two groups as placebo or experimental group. All the subjects were requested to drink either PMF (experimental) or skimmed milk drink formula-placebo (30 g mixed with 200 mL of water) for 10 weeks and continued by 2 weeks of the follow-up period. Supplementation of PMF for 10 weeks significantly improved (p < 0.05) the fecal weight, fecal movement (decreased fecal gastrointestinal passing time) by improving intestinal microbiota (increasing beneficial bacterial species like Lactobacillus, Bifidobacterium spp.), and lag time of low-density lipoprotein (LDL) oxidation. Also, intake of PMF substantially reduced (p < 0.05) the levels of total cholesterol (TC; 8.1%) and low-density lipoprotein cholesterol (LDL-c; 10.4%) and thus showcasing its cardioprotective efficacy. PMF considerably improves gastrointestinal function by modulating fecal movement, intestinal microbiota, and decrease cholesterol and might be helpful in the management of hypercholesterolemia. |
URI: | http://dx.doi.org/10.1007/s12602-020-09728-6 https://www.webofscience.com/wos/woscc/full-record/WOS:000605486100001 https://ir.csmu.edu.tw:8080/handle/310902500/23426 |
Relation: | PROBIOTICS AND ANTIMICROBIAL PROTEINS ,2021,v13,issue 3, P624-632 |
Appears in Collections: | [中山醫學大學研究成果] 期刊論文
|
Files in This Item:
File |
Description |
Size | Format | |
index.html | | 0Kb | HTML | 172 | View/Open |
|
All items in CSMUIR are protected by copyright, with all rights reserved.
|